EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease

Ichiro Kawahata, David I. Finkelstein, Kohji Fukunaga

Receptors · 12.04.2024 · 3 (2) · 155-181

DOI: 10.3390/receptors3020009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Receptors, online erschienen am 12.04.2024. Verfasst von Ichiro Kawahata und 2 weiteren Autor:innen. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, Australian National Health and Medical Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the intricate role of dopamine D1–D5 receptors is pivotal in addressing the challenges posed by the aging global population, as well as by social stress and advancing therapeutic interventions. Central to diverse brain functions such as movement, cognition, motivation, and reward, dopamine receptors are ubiquitously distributed across various brain nuclei. This comprehensive review explores the nuanced functions of each dopamine receptor, D1, D2, D3, D4, and D5, in distinct brain regions, elucidating the alterations witnessed in several neurological and psychiatric disorders. From the substantia nigra and ventral tegmental area, crucial for motor control and reward processing, to the limbic system influencing emotional responses, motivation, and cognitive functions, each brain nucleus reveals a specific involvement of dopamine receptors. In addition, genetic variations in dopamine receptors affect the risk of developing schizophrenia and parkinsonism. The review further investigates the physiological significance and pathogenic impacts of dopamine receptors in critical areas like the prefrontal cortex, hypothalamus, and striatum. By unraveling the complexities of dopamine receptor biology, especially those focused on different brain nuclei, this review provides a foundation for understanding their varied roles in health and disease, which is essential for the development of targeted therapeutic strategies aimed at mitigating the impact of aging and mental health on neurological well-being.

Förderung

  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Australian National Health and Medical Research Council
  • The Michael J. Fox Foundation for Parkinson’s Disease Research

Zitieren

APA

Kawahata, I., Finkelstein, D. I., & Fukunaga, K. (2024). Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease. Receptors, 3(2), 155-181. https://doi.org/10.3390/receptors3020009

Vancouver

Kawahata I, Finkelstein DI, Fukunaga K. Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease. Receptors. 2024;3(2):155-181. doi:10.3390/receptors3020009

BibTeX
@article{Kawahata2024,
  author = {Kawahata, Ichiro and Finkelstein, David I. and Fukunaga, Kohji},
  title = {Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease},
  journal = {Receptors},
  year = {2024},
  volume = {3},
  number = {2},
  pages = {155--181},
  doi = {10.3390/receptors3020009}
}
Kostenlos starten →